# Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer

> **NCT00828022** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Soroka University Medical Center** · enrollment: 15 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer
- Measles

## Interventions

- **BIOLOGICAL:** attenuated measles vaccine

## Key facts

- **NCT ID:** NCT00828022
- **Lead sponsor:** Soroka University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2009-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00828022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00828022, "Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00828022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*